Measured sleep outcomes, such as onset time and continuity. Direction and clinical meaning depend on the endpoint and population.
Measured endpoints are tied to a particular task, population, and exposure. A finding cannot be generalized to a different outcome without supporting evidence.
The sleep trial found disruption even when the studied exposure preceded bedtime by several hours. Source
Sleep began earlier with melatonin plus scheduling in the selected circadian-disorder population. Source
Each relationship keeps its participants and their roles together. Source details explain what the connection supports.
400 mg administered at bedtime or 3 or 6 hours before it.
Limitation One fixed exposure cannot establish a universal sleep cutoff.
Caffeine · Sourced draftSelected delayed sleep–wake phase disorder patients receiving fast-release melatonin with scheduling.
Limitation The protocol does not establish efficacy for all insomnia or long-term treatment.
Melatonin · Sourced draftFast-release melatonin with behavioral scheduling was studied in selected delayed sleep–wake phase disorder patients. The co-intervention is part of this relationship.
The sleep connection represents possible disruption, not a sleep benefit.
Tagged articles and participants in the relationships above. A shared tag alone does not establish a causal effect.
A familiar stimulant with an unusually rich evidence base. Its effects depend on timing, tolerance and how quickly your body clears it.
Sourced draftHormoneA hormone involved in circadian timing. Formulation, timing and the sleep problem being studied all matter.
Sourced draftSupporting reading for this original editorial definition. Independent editorial review has not been recorded.
The tested caffeine exposure disrupted sleep at each tested timing.
Limitation A single fixed exposure and a small sample do not define a universal bedtime cutoff.
Funding / disclosures Not assessed; consult the original disclosure.
Source in CaffeineMelatonin with scheduling improved sleep initiation in a selected circadian-disorder population.
Limitation Scheduling was part of treatment; long-term outcomes and broader insomnia populations were not established.
Funding / disclosures Not assessed; consult the original disclosure.
Source in Melatonin